Skip Navigation
Skip to contents

J Korean Ophthalmol Soc.  2007 Dec;48(12):1686-1693.

GDx-VCC Performance to Discriminate Normal, Pre-perimetric Glaucomatous Eyes

Affiliations
  • 1Department of Ophthalmology, Ewha Womans University College of Medicine, The Institute of Ophthalmology and Optometry, Seoul, Korea. ckrey02@mm.ewha.ac.kr

Abstract

PURPOSE: This study was designed to assess the diagnostic value of scanning laser polarimetry with variable corneal compensation (GDx-VCC) in the diagnosis of preperimetric glaucoma.
METHODS
The study included 132 eyes of 132 patients with normal intraocular pressure, including 38 normal eyes, 60 eyes with pre-perimetric glaucoma, and 34 eyes with early glaucoma. The parameters of GDx-VCC were analyzed and compared in these groups using ANOVA. The parameter with the most powerful diagnostic value was defermirred by an ROC curve, and it's sensitivity and specificity were calculated.
RESULTS
Among GDx-VCC parameters, NFI was the most valuable parameter that could detect pre-perimetric glaucoma in normal eyes. A cut-off value of 12 was the optimal NFI value, which offered the highest sensitivity and specificity in discriminating between normal and pre-perimetric glaucomatous eyes. However, there were no statistically significant differences in GDx-VCC parameters between pre-perimetric and early glaucomatous eyes. A statistically significant correlation was found between NFI and visual field indices in early glaucomatous eyes.
CONCLUSIONS
GDx-VCC can be useful as a screening test for early detection of pre-perimetric and early glaucoma with normal intraocular pressure.

Keyword

GDx-VCC; Pre-perimetric glaucoma; Scanning laser polarimetry

MeSH Terms

Compensation and Redress
Diagnosis
Glaucoma
Humans
Intraocular Pressure
Mass Screening
ROC Curve
Scanning Laser Polarimetry
Sensitivity and Specificity
Visual Fields
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr